55 related articles for article (PubMed ID: 38538206)
1. Reply: Evaluation of the Inclisiran Safety in High-Risk Populations.
Wright RS; Leiter LA; Lesogor A; Ray KK
J Am Coll Cardiol; 2024 Apr; 83(13):e129. PubMed ID: 38538207
[No Abstract] [Full Text] [Related]
2. Inclisiran: Where Are We on Safety, Efficacy, and Clinical Effectiveness of siRNA Therapies for Prevention?
Ballantyne CM; Minhas AMK; Orringer CE
J Am Coll Cardiol; 2023 Dec; 82(24):2262-2264. PubMed ID: 38057067
[No Abstract] [Full Text] [Related]
3. UK deal over inclisiran.
Byrne P; Cullinan J; Mintzes B; Smith SM
BMJ; 2020 Feb; 368():m579. PubMed ID: 32071100
[No Abstract] [Full Text] [Related]
4. Evaluation of the Inclisiran Safety in High-Risk Populations.
Jiang X; Zhang Z; Ding H
J Am Coll Cardiol; 2024 Apr; 83(13):e127. PubMed ID: 38538206
[No Abstract] [Full Text] [Related]
5. Inclisiran in dyslipidemia.
Kosmas CE; Muñoz Estrella A; Sourlas A; Pantou D
Drugs Today (Barc); 2021 May; 57(5):311-319. PubMed ID: 34061126
[TBL] [Abstract][Full Text] [Related]
6. Inclisiran: A Review in Hypercholesterolemia.
Frampton JE
Am J Cardiovasc Drugs; 2023 Mar; 23(2):219-230. PubMed ID: 36869996
[TBL] [Abstract][Full Text] [Related]
7. Inclisiran: A Novel Small Interfering RNA Drug for Low-Density Lipoprotein Reduction.
Smith KW; White CM
J Clin Pharmacol; 2022 Sep; 62(9):1079-1085. PubMed ID: 35279835
[TBL] [Abstract][Full Text] [Related]
8. Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia.
Banerjee Y; Pantea Stoian A; Cicero AFG; Fogacci F; Nikolic D; Sachinidis A; Rizvi AA; Janez A; Rizzo M
Expert Opin Drug Saf; 2022 Jan; 21(1):9-20. PubMed ID: 34596005
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease.
Tomlinson B; Chow E; Chan P; Lam CWK
Expert Opin Drug Metab Toxicol; 2021 Dec; 17(12):1353-1361. PubMed ID: 35025707
[TBL] [Abstract][Full Text] [Related]
10. Inclisiran, the billion-dollar drug, to lower LDL cholesterol - is it worth it?
Doggrell SA
Expert Opin Pharmacother; 2020 Nov; 21(16):1971-1974. PubMed ID: 32749892
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
